类风湿关节炎相关间质性肺病的模式与死亡率
该单中心队列纳入1998至2014年Mayo Clinic的181例RA相关间质性肺病(ILD)患者,评估其临床特征、生存情况及GAP与ILD-GAP分期系统的效用。结果显示5年生存率为59.7%(95%CI 51.5, 69.2),不同ILD类型间生存无差异(P=0.42),GAP模型判别与校准表现良好(c-statistic 0.71,标准化发病比0.97)。
要点
- RA-ILD患者5年生存率为59.7%,死亡率较高。
- UIP、NSIP与机化性肺炎间生存无差异(P=0.42)。
- GAP模型在该队列中判别与校准表现良好,可用于死亡风险评估。
核心结论
- RA相关ILD患者死亡率高,且不因ILD类型而异,GAP模型可能有助于评估死亡风险。
研究设计与样本
- 1998至2014年Mayo Clinic单中心回顾性队列,共纳入181例RA相关ILD患者,人工筛选入组并评估RA疾病特征、高分辨率CT与肺功能检查,采用Kaplan-Meier法估计生存。
主要发现
- 患者96%为白人、48%为女性、37%从不吸烟,ILD诊断平均年龄67.4岁(s.d. 9.9),RA诊断至ILD中位时间4.9年(范围-10.9至48.1),中位随访3.1年(范围0.01至14.8)。
- 多变量模型中年龄、RA病程和初始一氧化碳弥散量低可预测过早死亡,而性别、吸烟状态、阻塞性肺病、血清阳性和侵蚀性疾病与死亡率无关。
- 5年生存率为59.7%(95%CI 51.5, 69.2),UIP、NSIP与机化性肺炎间生存无差异(P=0.42)。
- GAP模型判别与校准良好(c-statistic 0.71,标准化发病比0.97)。
关键数值与推荐
- 5年生存率59.7%(95%CI 51.5, 69.2)。
- UIP、NSIP与机化性肺炎生存比较P=0.42。
- GAP模型c-statistic 0.71,标准化发病比0.97。
临床怎么用
- 对RA-ILD患者可考虑使用GAP模型辅助死亡风险评估,并关注年龄、RA病程及初始弥散功能等预后因素。
局限性
- 单中心回顾性队列,患者以白人为主,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize a cohort of patients with RA who have interstitial lung disease (ILD) and to assess the utility of previously developed mortality staging systems [gender, age, lung physiology (GAP) and ILD-GAP]. METHODS: All patients with RA and ILD seen at the Mayo Clinic from 1998 to 2014 were identified and manually screened for study inclusion. RA disease characteristics and pulmonary findings including high-resolution CT and pulmonary function testing were evaluated. Survival was estimated using Kaplan-Meier methods. GAP and ILD-GAP models were evaluated using c-statistics and standardized incidence ratios. RESULTS: The study included 181 patients with RA-associated ILD (96% Caucasian; 48% females; 37% never-smokers). The mean age at ILD diagnosis was 67.4 years ( s . d . 9.9). The median time from RA diagnosis to ILD was 4.9 years (range -10.9-48.1). The median follow-up was 3.1 years (range 0.01-14.8). Age, RA disease duration and low initial diffusing capacity for carbon monoxide were predictive of premature mortality in multivariate modelling. Sex, smoking status, obstructive lung disease, seropositivity and erosive disease were not associated with mortality. The 5-year survival rate was 59.7% (95% CI 51.5, 69.2). Survival did not differ between usual interstitial pneumonia, non-specific interstitial pneumonia and organizing pneumonia ( P = 0.42). The GAP model performed well in this cohort for both discrimination and calibration (c-statistic 0.71, standardized incidence ratio 0.97). CONCLUSION: In this large single-centre cohort of patients with RA-ILD, most patients were seropositive and had a history of smoking. ILD most commonly occurred after the RA diagnosis. Mortality was high and did not differ among the types. The GAP model may be useful in assessing mortality risk.
引用
- Zamora-Legoff JA, Krause ML, Crowson CS, et al. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatology (Oxford). 2017. PMID: 27940586. doi:10.1093/rheumatology/kew391
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。